Barclays initiates coverage on U.S. small & mid-cap biotech stocks
PositiveFinancial Markets

Barclays has started covering U.S. small and mid-cap biotech stocks, signaling a positive outlook for this sector. This move is significant as it highlights the growing interest and potential in smaller biotech companies, which often drive innovation in healthcare. Investors may find new opportunities as Barclays provides insights and analysis on these stocks, potentially leading to increased investment in the biotech field.
— Curated by the World Pulse Now AI Editorial System